Neurobiological Technologies, Inc.
NTII · OTC
6/30/2010 | 6/30/2009 | 6/30/2008 | 6/30/2007 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | $3,123 | -$16,322 | -$14,128 |
| Dep. & Amort. | – | $132 | $205 | $230 |
| Deferred Tax | – | $0 | $0 | $0 |
| Stock-Based Comp. | – | $625 | $1,006 | $0 |
| Change in WC | – | -$21,618 | -$6,322 | $765 |
| Other Non-Cash | – | $1,309 | $736 | -$21 |
| Operating Cash Flow | – | -$16,429 | -$20,697 | -$13,154 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$2 | -$11 | -$66 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | -$42,078 | -$22,918 | -$52,014 |
| Inv. Sales/Matur. | – | $38,797 | $11,166 | $54,172 |
| Other Inv. Act. | – | $0 | $0 | $0 |
| Investing Cash Flow | – | -$3,283 | -$11,763 | $2,092 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | -$6,000 | $0 |
| Stock Issued | – | $0 | $60,821 | $6,863 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $1 | $42 | $0 |
| Financing Cash Flow | – | $1 | $54,863 | $6,863 |
| Forex Effect | – | $0 | $0 | $0 |
| Net Chg. in Cash | – | -$19,711 | $22,403 | -$4,199 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $27,941 | $5,538 | $9,737 |
| End Cash | – | $8,230 | $27,941 | $5,538 |
| Free Cash Flow | – | -$16,431 | -$20,708 | -$13,220 |